Valuation Cuorips Inc.

Stocks

Market Closed - Japan Exchange 12:00:00 06/11/2026 pm IST			5-day change	1st Jan Change
6,050.00 ^JPY	-7.63%		-17.69%	+0.33%

28/09	Cuorips Inc. announced that it has received ¥2.9999677 billion in funding from JIC Venture Growth Investments Co., Ltd.	CI
11/09	Cuorips Inc. announced that it expects to receive ¥2.9999677 billion in funding from JIC Venture Growth Investments Co., Ltd.	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2024	2025	2026
Market Cap ¹	29,126	67,173	57,885
Change	-	130.63%	-13.83%
Enterprise Value (EV) ¹	23,544	62,380	53,986
Change	-	164.96%	-13.46%
P/E	-43x	-103x	-56.3x
PBR	4.91x	12.2x	12.2x
PEG	-	16.48x	-1x
Capitalization / Revenue	1,266x	384x	273x
EV / Revenue	1,024x	356x	255x
EV / EBITDA	-45.5x	-121x	-54.1x
EV / EBIT	-40x	-106x	-49.9x
EV / FCF	-	-	-
FCF Yield	-	-	-
Dividend per Share ²	-	-	-
Rate of return	-	-	-
EPS ²	-85.84	-80.48	-124.5
Distribution rate	-	-	-
Net sales ¹	23	175	212
EBITDA ¹	-518	-514	-997
EBIT ¹	-588	-590	-1,081
Net income ¹	-632	-644	-1,022
Net Debt ¹	-5,582	-4,793	-3,899
Reference price ²	3,695.00	8,310.00	7,010.00
Nbr of stocks (in thousands)	7,882	8,083	8,258
Announcement Date	27/06/24	20/06/25	24/06/26

¹JPY in Million²JPY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
CUORIPS INC.	-	-	-	-	37Cr
ELI LILLY AND COMPANY	39.94x	13.51x	30.01x	0.5%	1,21600Cr
JOHNSON & JOHNSON	39.86x	6.69x	18.83x	1.96%	66TCr
ABBVIE INC.	37.08x	8.43x	17.39x	2.4%	51TCr
ROCHE HOLDING AG	21.12x	5.13x	12.77x	2.56%	38TCr
MERCK & CO., INC.	97.32x	5.95x	25.36x	2.32%	36TCr
NOVARTIS AG	23.5x	6.02x	14.53x	2.65%	31TCr
ASTRAZENECA PLC	24.85x	4.96x	13.98x	1.76%	29TCr
AMGEN INC.	28.41x	7.33x	12.69x	2.19%	25TCr
GILEAD SCIENCES, INC.	-40.11x	7.32x	45.99x	1.97%	21TCr
Average	30.22x	7.26x	21.28x	2.03%	41.88TCr
Weighted average by Cap.	35.88x	8.57x	22.23x	1.73%